Whalegun
Home

Amneal Pharmaceuticals AMRX paid Tarplin, Downs & Young $60K for lobbying in Q3 2025 · Health Issues

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q3 2025
Stock
Amneal Pharmaceuticals AMRX
Client
Amneal Pharmaceuticals
Reported
25/10/16

Up 0.0% from last quarter

What else happened in Amneal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Amneal Pharmaceuticals's other lobbying reports